Fucosidase inhibitor
First Claim
Patent Images
1. The method of inhibiting α
- -L-fucosidase in a biological fluid comprising subjecting said biological fluid to an inhibitory effective amount of 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco-heptitol in the free base or biologically acceptable salt form.
0 Assignments
0 Petitions
Accused Products
Abstract
The synthesis of the novel fucosidase inhibitor, 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco heptitol, is disclosed.
-
Citations
1 Claim
-
1. The method of inhibiting α
- -L-fucosidase in a biological fluid comprising subjecting said biological fluid to an inhibitory effective amount of 2,6-imino-2,6,7-trideoxy-D-glycero-D-gluco-heptitol in the free base or biologically acceptable salt form.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeMonsanto Company (Bayer AG)
-
Original AssigneeMonsanto Company (Bayer AG)
-
InventorsFleet, George W. J., Namgoong, Sung K.
-
Primary Examiner(s)SIEGEL, ALAN M
-
Application NumberUS07/600,941Time in Patent Office512 DaysField of Search514/315US Class Current514/315CPC Class CodesC07D 211/46 having a hydrogen atom as t...
